Advertisement
Screener

ACCURAY INCORPORATED (ARAY) Payments of Financing Costs

1.5 / 5 stars · 30/102 Roast Me

ACCURAY INCORPORATED Payments of Financing Costs

ACCURAY INCORPORATED (ARAY) reported Payments of Financing Costs of $1.14 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-27

  • ACCURAY INCORPORATED payments of financing costs for the quarter ending 2026-06-30 was $255.00K, a 98.06% decline year-over-year.
  • ACCURAY INCORPORATED payments of financing costs for the quarter ending 2026-03-31 was $512.00K.
  • ACCURAY INCORPORATED payments of financing costs for the quarter ending 2025-12-31 was $375.00K.
  • ACCURAY INCORPORATED payments of financing costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • ACCURAY INCORPORATED payments of financing costs for fiscal 2026 was $1.14M, a 91.41% decline from fiscal 2025.
  • ACCURAY INCORPORATED payments of financing costs for fiscal 2025 was $13.29M, a 16306.17% increase from fiscal 2024.
  • ACCURAY INCORPORATED payments of financing costs for fiscal 2024 was $81.00K.
Period endPayments of Financing Costs 3 monthPayments of Financing Costs 6 monthPayments of Financing Costs 9 monthPayments of Financing Costs 12 month
2026-06-30$255.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
$767.00K
derived: sum of 2 quarters · filed 2026-08-27
$1.14M
derived: sum of 3 quarters · filed 2026-08-27
$1.14M
10-K · filed 2026-08-27
2026-03-31$512.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$887.00K
derived: sum of 2 quarters · filed 2026-05-06
$887.00K
10-Q · filed 2026-05-06
$14.00M
derived: sum of 4 quarters · filed 2026-08-27
2025-12-31$375.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-17
$375.00K
10-Q · filed 2026-02-17
$13.49M
derived: sum of 3 quarters · filed 2026-08-27
$13.49M
derived: sum of 4 quarters · filed 2026-08-27
2025-09-30$0.00
10-Q/A · filed 2026-02-17
$13.12M
derived: sum of 2 quarters · filed 2026-08-27
$13.12M
derived: sum of 3 quarters · filed 2026-08-27
$13.12M
derived: sum of 4 quarters · filed 2026-08-27
2025-06-30$13.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
$13.12M
derived: sum of 2 quarters · filed 2026-08-27
$13.12M
derived: sum of 3 quarters · filed 2026-08-27
$13.29M
10-K · filed 2026-08-27
2025-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
$0.00
derived: sum of 2 quarters · filed 2026-05-06
$173.00K
10-Q · filed 2026-05-06
2024-12-31$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-17
$173.00K
10-Q · filed 2026-02-17
2024-09-30$173.00K
10-Q/A · filed 2026-02-17
2024-06-30$81.00K
10-K/A · filed 2026-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Glucotrack, Inc. (GCTK)United States$0.027B
PAVmed Inc. (PAVM)United States$0.031B-3.00
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
InspireMD, Inc. (NSPR)$0.033B
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10